A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis

Clinical trial NCT02016716 · COMPLETED

Trial details

NCT number: NCT02016716
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2013-12-03
Primary completion: 2014-09-08
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.